Cargando…
The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
PURPOSE: This study was aimed at exploring the regulatory mechanism of Xiaoyao San (XYS) and its main compound, Stigmasterol, in the biological network and signaling pathway of ovarian cancer (OC) through network pharmacology-based analyses and experimental validation. METHODS: The active compounds...
Autores principales: | Li, Meng, Zhang, Wenqi, Yang, Linqi, Wang, Huibing, Wang, Yihan, Huang, Kai, Zhang, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263223/ https://www.ncbi.nlm.nih.gov/pubmed/34306252 http://dx.doi.org/10.1155/2021/4304507 |
Ejemplares similares
-
Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway
por: Markers, Disease
Publicado: (2023) -
Mechanism of Action of Xiaoyao San in Treatment of Ischemic Stroke is Related to Anti-Apoptosis and Activation of PI3K/Akt Pathway
por: Xu, Yue, et al.
Publicado: (2021) -
DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway
por: Li, Meng, et al.
Publicado: (2022) -
Jiawei Xiaoyao San in treatment of anxiety disorder and anxiety: A review
por: Xie, Jiaqi, et al.
Publicado: (2023) -
Effectiveness and potential mechanism of Jiawei-Xiaoyao-San for hyperthyroidism: a systematic review
por: Ma, Wenxin, et al.
Publicado: (2023)